Novo Nordisk's head of research has his sights set on a new pill that "to a great extent" can beat competitors in weight loss

Right now, the Wegovy pill is surging in the USA. At the same time, Novo Nordisk is testing a new pill which, according to head of research Martin Holst Lange, has the potential to sweep all future pill competitors off the market.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskenno46d ago

Novo Nordisks forskningschef har blikket rettet mod ny pille, som »i den grad« kan slå konkurrenter på vægttab

Lige nu stormer Wegovy-pillen frem i USA. Samtidig tester Novo Nordisk en ny pille, som ifølge forskningschef Martin Holst Lange har potentiale til at feje alle fremtidige pille-konkurrenter af banen. Men er det nok til at få Novo Nordisk tilbage på sporet?

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk's head of research has his sights set on a new pill that "to a great extent" can beat competitors in weight loss

Sources

Novo Nordisks forskningschef har blikket rettet mod ny pille, som »i den grad« kan slå konkurrenter på vægttab

Related Stories

Philippines Health Secretary Herbosa calls expired medicine complaints a 'demolition job'

PhilHealth eyes accreditation of pediatric neurologists for autism care

Norway's Crown Princess Mette-Marit Appears with Oxygen Device

Dietitian Shares Strategy for Including Protein in Every Meal

PERSPECTA